These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22260696)

  • 21. Notexin upregulates Fas and FasL protein expression of human neuroblastoma SK-N-SH cells through p38 MAPK/ATF-2 and JNK/c-Jun pathways.
    Chen KC; Chang LS
    Toxicon; 2010 Apr; 55(4):754-61. PubMed ID: 19944115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-1beta and tetradecanoylphorbol acetate-induced biosynthesis of tumor necrosis factor alpha in human hepatoma cells involves the transcription factors ATF2 and c-Jun and stress-activated protein kinases.
    Bauer I; Al Sarraj J; Vinson C; Larsen R; Thiel G
    J Cell Biochem; 2007 Jan; 100(1):242-55. PubMed ID: 16888805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p38beta2-mediated phosphorylation and sumoylation of ATF7 are mutually exclusive.
    Camuzeaux B; Diring J; Hamard PJ; Oulad-Abdelghani M; Donzeau M; Vigneron M; Kedinger C; Chatton B
    J Mol Biol; 2008 Dec; 384(4):980-91. PubMed ID: 18950637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal transactivation domain of ATF2 is a target for the co-operative activation of the c-jun promoter by p300 and 12S E1A.
    Duyndam MC; van Dam H; Smits PH; Verlaan M; van der Eb AJ; Zantema A
    Oncogene; 1999 Apr; 18(14):2311-21. PubMed ID: 10327051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of human myometrial target genes of the c-Jun NH2-terminal kinase (JNK) pathway: the role of activating transcription factor 2 (ATF2) and a novel spliced isoform ATF2-small.
    Bailey J; Europe-Finner GN
    J Mol Endocrinol; 2005 Feb; 34(1):19-35. PubMed ID: 15691875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
    Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
    J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of early response genes in trypsin inhibitor-induced pancreatic growth.
    Guo L; Sans MD; Gurda GT; Lee SH; Ernst SA; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G667-77. PubMed ID: 17095753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibronectin gene expression in aortic regurgitation: relative roles of mitogen-activated protein kinases.
    Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Ene AR; Herrold EM; Dumlao TF; Beltran F; Borer JS
    Cardiology; 2009; 113(4):291-8. PubMed ID: 19299894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The c-Jun NH(2)-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastine.
    Fan M; Goodwin ME; Birrer MJ; Chambers TC
    Cancer Res; 2001 Jun; 61(11):4450-8. PubMed ID: 11389075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
    Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
    J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA; Merlino G
    Oncogene; 2002 Feb; 21(7):1000-8. PubMed ID: 11850817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of activating transcription factor-2 is required for tumor growth and progression in mouse skin tumors.
    Papassava P; Gorgoulis VG; Papaevangeliou D; Vlahopoulos S; van Dam H; Zoumpourlis V
    Cancer Res; 2004 Dec; 64(23):8573-84. PubMed ID: 15574764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
    Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
    Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of ATF3 by ionizing radiation is mediated via a signaling pathway that includes ATM, Nibrin1, stress-induced MAPkinases and ATF-2.
    Kool J; Hamdi M; Cornelissen-Steijger P; van der Eb AJ; Terleth C; van Dam H
    Oncogene; 2003 Jul; 22(27):4235-42. PubMed ID: 12833146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-1 and TNF induction of matrix metalloproteinase-3 by c-Jun N-terminal kinase in trabecular meshwork.
    Hosseini M; Rose AY; Song K; Bohan C; Alexander JP; Kelley MJ; Acott TS
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1469-76. PubMed ID: 16565381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.
    Diring J; Camuzeaux B; Donzeau M; Vigneron M; Rosa-Calatrava M; Kedinger C; Chatton B
    PLoS One; 2011; 6(8):e23351. PubMed ID: 21858082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.